Current treatment status-Did not start treatment yet - Page 24 of 37 Posts on Medivizor
Navigation Menu

Current treatment status-Did not start treatment yet Posts on Medivizor

Does trastuzumab increase the risk of infection?

Does trastuzumab increase the risk of infection?

Posted by on Aug 9, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to determine whether or not the breast cancer treatment trastuzumab (Herceptin) increased the risk of developing certain infections. Some background Human epidermal growth factor receptor positive (HER2+) breast cancers are dependent on the HER2 protein for growth. It is often targeted with a particular...

Read More

Looking for prostate cancer patients to evaluate the benefits of hypo-fractionated radiation therapy

Posted by on Aug 7, 2015 in Prostate cancer | 0 comments

In a nutshell This phase III trial aims to determine the effects of hypo-fractionated radiation compared to standard radiation therapy. The main outcome to be investigated is whether hypo-fractionated radiation has similar or better results when compared to standard radiation. This trial is recruiting in in Illinois, Oklahoma and Virginia, in the...

Read More

Can hormone therapy affect mental function?

Can hormone therapy affect mental function?

Posted by on Jul 26, 2015 in Prostate cancer | 0 comments

In a nutshell The authors determined whether hormone therapy had a negative impact on mental function (cognitive performance) in prostate cancer patients.  Some background Hormone therapy is a common treatment used in prostate cancer. It targets the male sex hormones involved in prostate cancer, such as testosterone. Some studies have...

Read More

Treatment options for eye melanoma: a review

Treatment options for eye melanoma: a review

Posted by on Jul 26, 2015 in Melanoma | 0 comments

In a nutshell The authors reviewed the biology as well as current and future treatment options for eye melanoma.  Some background Uveal melanoma is a rare cancer (melanoma) of the eye. It involves three parts of the eye (iris, ciliary body and choroid) known together as the uvea. Eye melanoma is associated with a high risk...

Read More

Can a trastuzumab-combination chemotherapy treatment cause skin and nail infections?

Can a trastuzumab-combination chemotherapy treatment cause skin and nail infections?

Posted by on Jul 21, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to determine whether severe skin and nail infections observed in patients with breast cancer were due to a combination-chemotherapy treatment. Some background Trastuzumab (Herceptin) is a common drug used to treat patients with human epidermal growth factor 2 positive (HER2+) breast cancer. The HER2 protein can...

Read More

What factors are associated with better outcomes in patients with lung cancer treated with radiotherapy?

What factors are associated with better outcomes in patients with lung cancer treated with radiotherapy?

Posted by on Jul 18, 2015 in Lung cancer | 0 comments

In a nutshell The authors evaluated the factors associated with improved outcomes in patients with lung cancer treated with stereotactic body radiotherapy (SBRT). Some background Stereotactic body radiotherapy (SBRT) is a type of radiotherapy used to treat lung cancer.  With SBRT, a beam of radiation is focused directly on the tumor,...

Read More

Risk factors for disease reclassification in prostate cancer patients on active surveillance

Risk factors for disease reclassification  in prostate cancer patients on active surveillance

Posted by on Jul 16, 2015 in Prostate cancer | 0 comments

In a nutshell The authors determined the risk factors that led to disease reclassification (change in grade/status of the disease) in prostate cancer patients under active surveillance. Some background Active surveillance is common in early-stage prostate cancer management. It involves active monitoring of patients for any changes in symptoms or...

Read More